Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Topotecan. Show all posts
Showing posts with label Topotecan. Show all posts
Thursday, May 17, 2012

Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) - Full Text View - ClinicalTrials.gov

›
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) - Full Text View - ClinicalTrials.gov
Tuesday, January 24, 2012

abstract: Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial (GINECO)

›
Conclusions: Combination chemotherapy in platinum-resistant ROC ( recurrent ovarian cancer ) was more toxic than weekly paclitaxel and did...
Saturday, August 06, 2011

A weekly topotecan and biweekly bevacizumab combination demonstrates acceptable toxicity and encouraging efficacy in patients with platinum-resistant

›
Note: pay particular attention to the side effects/adverse events
Saturday, May 21, 2011

Markman commentary: Can weekly topotecan substitute for a multi-day regimen in the treatment of ovarian cancer? Sadly, 10 years later the answer remains unknown

›
Gynecologic Oncology Article in Press doi:10.1016/j.ygyno.2011.04.020  |  How to Cite or Link Using DOI C...

abstract: Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer:

›
CONCLUSIONS: Combination chemotherapy in platinum-resistant ROC was more toxic than weekly paclitaxel and did not significantly prolong PF...
Wednesday, March 09, 2011

abstract: A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: (GOG 146Q)

›
Sunday, November 14, 2010

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.

›
Monday, October 11, 2010

Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival

›
Blogger's Note: discussions/research have been made in the past regarding triple therapies (irrespective of types of therapies) with mo...
Tuesday, August 17, 2010

2010 Review: Cochrane Collaboration Topotecan for ovarian cancer

›
Background Chemotherapeutic agents such as topotecan can be used to treat ovarian cancer. The effects of using topotecan as a therapeutic a...
Tuesday, June 15, 2010

Efficacy of lower dose of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer resistant to platinum-based therapy

›
Conclusions: Lower dose of weekly topotecan was well tolerated in patients with platinum-resistant ovarian or peritoneal cancer at fir...
Wednesday, April 07, 2010

Bridging the Gap between Cytotoxic and Biologic Therapy with Metronomic Topotecan and Pazopanib in Ovarian Cancer

›
"Pazopanib therapy in combination with metronomic topotecan therapy showed significant antitumor and antiangiogenic properties in precl...
Wednesday, March 31, 2010

A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies

›